Related Experiment Video
Updated: May 25, 2026
08:07
Rose Bengal Photothrombosis by Confocal Optical Imaging In Vivo: A Model of Single Vessel Stroke
Published on: June 23, 2015
Anticoagulation in neurointerventions: basic pharmacology and pathophysiology, current status, practical advice.
1Departement of Neuroradiology, Faculty of Clinical Medicine, Mannheim University of Heidelberg, Theodor-Kutzer-Ufer 1-3, Mannheim, Germany. johann.scharf@umm.de
Clinical Neuroradiology
|February 8, 2012
Summary
This article reviews anticoagulative medications for neurointerventional procedures, discussing their pharmacology, risks, benefits, and monitoring. It presents a customized care plan for optimizing patient outcomes during these interventions.
Area of Science:
- Neurology
- Pharmacology
- Interventional Radiology
Background:
- Neurointerventional procedures carry inherent thrombotic risks.
- Anticoagulative medications are crucial for managing these risks.
- Standardized protocols for medication use are lacking.
Purpose of the Study:
- To provide an overview of anticoagulative medication in neurointerventional procedures.
- To outline the pharmacology of commonly used anticoagulants.
- To present a customized care regimen for these interventions.
Main Methods:
- Literature review of anticoagulative medications and neurointerventional procedures.
- Description of the pharmacology of prevalent anticoagulative agents.
- Analysis of risks, benefits, and monitoring strategies for anticoagulation.
Main Results:
- Detailed pharmacology of key anticoagulative drugs.
- Assessment of thrombogenicity associated with standard neurointerventional procedures.
- Evidence-based review of medication risks, benefits, and monitoring.
Conclusions:
- A comprehensive understanding of anticoagulation is vital for neurointerventional procedures.
- A customized care plan can optimize safety and efficacy.
- Further research into tailored anticoagulation strategies is warranted.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:30Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...